Roberta Lorenzon

The paper identifies a shared Treg dysfunction signature across rheumatic diseases, suggesting a therapeutic window of opportunity for Treg-targeted treatments.

The paper develops a gene signature to distinguish type 1 diabetic patients from healthy donors using whole blood transcriptomic data, finding that combining multiple analytical methods improves classification accuracy.

This study identifies Treg dysfunction as associated with OA-related pain through multi-omic analysis of peripheral blood from knee OA patients.

This study shows IL-1β signaling affects Tfh and Tfr cells in human lymphoid tissues, linking it to autoantibody production and autoimmune disease.